Menu

ISTOCK, BLACKJACK3D

Support for histone code?

Four papers released online today detail some of the work from David Allis's group and others on chromatin remodeling. 

May 22, 2006
Brendan Maher

Four papers released online today detail some of the work from David Allis's group and others that's detailed in our recent article on chromatin remodeling. In two Nature papers released today, Allis, a Rockefeller chromatin researcher, along with postdocs Joanna Wysocka and Tomek Swigut and a team led by structural biologist Dinshaw Patel, from Memorial Sloan Kettering, report on BPTF, the largest subunit of the nucleosome remodeling factor (NURF). It contains a so-called PHD finger which they've now shown preferentially binds histone 3 trimethylated at lysine 4. They found the protein in pull-down assays and it appears to maintain activity at developmentally critical HOX genes. 

This work is notable for adding support to the controversial histone code hypothesis. The structural work reveals an alpha helix between the PHD finger and a bromodomain. Bromodomain motifs are well known to recognize acetylated lysines, so that unstructured alpha helix might be acting as a spacer between the two recognition motifs. The authors write "The extent to which paired PHD finger-bromodomain in BPTF recognizes combinatorialy methyl and acetyl marks in one or multiple tails, in keeping with the histone code hypothesis remains to be determined." 

I saw Allis give a very engaging talk at Thomas Jefferson University last Thursday, and he was hinting that the "multiple tails" option was looking pretty good. But just in case the relationship between PHD fingers and gene activity sounded straightforward enough, the two other Nature papers released at the same time (and presumably being published in the same print issue) complicate issues, revealing that the PHD domain of tumor suppressor ING2 also recognizes trimethylated H3K4. This is puzzling because ING2 is closely associated with the mSin3a-HDAC1 histone deacetylase, a complex that represses gene transcription. 

Or Gozani at Stanford, Tatiana Kutateladze at University of Colorado Health Science Center and their respective collaborating groups published two papers describing the function and structure of ING2 and its ability to block gene transcription after DNA damage. This is the first protein to link H3K4 methylation to transcriptional repression, and it does it through the same recognition motif (the PHD finger) that Allis's papers describe. They write, "Together, our findings highlight the notion that the recognition of chromatin modifications by effector proteins rather than specific modification per se, determines biological function, and, as such, greatly expands the diversity of signaling at chromatin." 

Allis told me he thought it was fascinating that the same mark (H3K4 trimethylated) might signal both expression and repression. Some researchers argue that if the same signal gives different, even opposite readouts , then there can't be a predictive system. But the context of other signals around H3K4 methylation may play a role in this and other situations.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!